Yuya Tomioka

4PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 26, 2026
AKT Inhibitor Capivasertib as a Target for Osimertinib Combination Therapy in Lung Adenocarcinoma with EGFR Mutation.

|Aug 13, 2026
MicroRNA Signatures of Fulvestrant-Treated Luminal Breast Cancer Cells: Identification of Therapeutic Targets Regulated by miR-374b-5p.

|Jul 28, 2026
The microRNA Expression Signature of Lung Adenocarcinoma Harboring EGFR Mutations: Identification of Therapeutic Targets for EGFR-TKI Combination Therapy.

|Jul 29, 2025
MicroRNA Signatures in Lung Adenocarcinoma Metastases: Exploring the Oncogenic Targets of Tumor-Suppressive miR-195-5p and miR-195-3p.

Yuya Tomioka, Naohiko Seki, Keiko Mizuno

Pageof 1

Frequent Collaborators

4 joint publications

Naohiko Seki

3 joint publications

Keiko Mizuno

3 joint publications

Takuya Tokunaga

3 joint publications

Ayako Nagata